Yasuhiro Honda, MD

Publications

• Duplex criteria for in-stent restenosis in the superficial femoral artery. Kawarada O, Higashimori A, Noguchi M, Waratani N, Yoshida M, Fujihara M, Yokoi Y, Honda Y, Fitzgerald PJ. Catheter Cardiovasc Interv. 2013; 81 (4): E199-205
• Improved automated lumen contour detection by novel multifrequency processing algorithm with current intravascular ultrasound system. Kume T, Kim BK, Waseda K, Sathyanarayana S, Li W, Teo TJ, Yock PG, Fitzgerald PJ, Honda Y. Catheter Cardiovasc Interv. 2013; 81 (3): E173-7
• Intravascular ultrasound analysis of small vessel lesions treated with the sparrow coronary stent system: Results of the care II trial. Kume T, Waseda K, Koo BK, Yock PG, Botelho R, Verheye S, Whitbourn R, Meredith I, Worthley S, Tian Hai K, Honda Y, Abizaid A, Fitzgerald PJ. Catheter Cardiovasc Interv. 2013
• Variability in quantitative and qualitative analysis of intravascular ultrasound and frequency domain optical coherence tomography. Abnousi F, Waseda K, Kume T, Otake H, Kawarada O, Yong CM, Fitzgerald PJ, Honda Y, Yeung AC, Fearon WF. Catheter Cardiovasc Interv. 2013
• Intravascular ultrasound insights from the Cobalt Chromium Stent With Antiproliferative for Restenosis II (COSTAR II) trial comparing CoStar and Taxus paclitaxel-eluting stents. Tsujino I, Koizumi T, Shimohama T, Ako J, Waseda K, Krucoff M, Honda Y, Fitzgerald PJ. Cardiovasc Revasc Med. 2012 Mar-Apr; 13 (2): 111-8
• Cardiovascular imaging for percutaneous coronary interventions Yamada R, Honda Y. Evidence Based Medicine: Treatment of Cardiovascular Disease 2012-2013. 2012: 105-112
• Comparison of vascular response to the everolimus-eluting stent versus the paclitaxel-eluting stent: intravascular ultrasound results from the SPIRIT III trial. Yamasaki M, Tsujino I, Lima-Filho MO, Ako J, Shimohama T, Hasegawa T, Sakurai R, Sudhir K, Stone GW, Waseda K, Honda Y, Fitzgerald PJ. EuroIntervention. 2012; 8 (6): 724-31
• Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. Tearney GJ, Regar E, Akasaka T, Adriaenssens T, Barlis P, Bezerra HG, Bouma B, Bruining N, Cho JM, Chowdhary S, Costa MA, de Silva R, Dijkstra J, Di Mario C, Dudek D, Dudeck D, Falk E, Falk E, Feldman MD, Fitzgerald P, Garcia-Garcia HM, Garcia H, Gonzalo N, Granada JF, Guagliumi G, Holm NR, Honda Y, Ikeno F, Kawasaki M, Kochman J, Koltowski L, Kubo T, Kume T, Kyono H, Lam CC, Lamouche G, Lee DP, Leon MB, Maehara A, Manfrini O, Mintz GS, Mizuno K, Morel MA, Nadkarni S, Okura H, Otake H, Pietrasik A, Prati F, Räber L, Radu MD, Rieber J, Riga M, Rollins A, Rosenberg M, Sirbu V, Serruys PW, Shimada K, Shinke T, Shite J, Siegel E, Sonoda S, Sonada S, Suter M, Takarada S, Tanaka A, Terashima M, Thim T, Troels T, Uemura S, Ughi GJ, van Beusekom HM, van der Steen AF, van Es GA, van Es GA, van Soest G, Virmani R, Waxman S, Weissman NJ, Weisz G. J Am Coll Cardiol. 2012; 59 (12): 1058-72
• Evaluation of the peri-strut low intensity area following sirolimus- and paclitaxel-eluting stents implantation: insights from an optical coherence tomography study in humans. Otake H, Shite J, Ikeno F, Shinke T, Teramoto T, Miyoshi N, Ako J, Honda Y, Fitzgerald PJ, Hirata K. Int J Cardiol. 2012; 157 (1): 38-42
• Impact of diabetes mellitus on vessel response in the drug-eluting stent era: pooled volumetric intravascular ultrasound analyses. Sakata K, Waseda K, Kume T, Otake H, Nakatani D, Yock PG, Fitzgerald PJ, Honda Y. Circ Cardiovasc Interv. 2012; 5 (6): 763-71
• Intravascular ultrasound Hahn JY, Honda Y, Fitzgerald PJ. Catheter-Based Cardiovascular Interventions: A Knowledge-Based Approach. 2012: 325-345
• Intravascular ultrasound assessment of postprocedural incomplete stent apposition. Kume T, Waseda K, Ako J, Sakata K, Yamasaki M, Shimohama T, Tsujino I, Hasegawa T, Fitzgerald PJ, Honda Y. J Invasive Cardiol. 2012; 24 (1): 13-6
• Intravascular ultrasound comparison of small coronary lesions between novel guidewire-based sirolimus-eluting stents and conventional sirolimus-eluting stents. Kume T, Waseda K, Koo BK, Botelho R, Verheye S, Whitbourn R, Meredith I, Worthley S, Hai KT, Yock PG, Azevedo de Oliveira FR, Abizaid A, Fitzgerald PJ, Honda Y. J Invasive Cardiol. 2012; 24 (10): 489-93
• Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Kawarada O, Fujihara M, Higashimori A, Yokoi Y, Honda Y, Fitzgerald PJ. Catheter Cardiovasc Interv. 2012; 80 (5): 861-71
• World Report: Up-to-Date. Stanford University Honda Y, Circulation Up-to-Date. 2012; 7 (2): 164-166
• Assessment of macro- and microcirculation in contemporary critical limb ischemia. Kawarada O, Yokoi Y, Higashimori A, Waratani N, Fujihara M, Kume T, Sakata K, Honda Y, Fitzgerald PJ. Catheter Cardiovasc Interv. 2011; 78 (7): 1051-8
• Coronary artery physiology: intracoronary ultrasonography, coronary flow velocity and pressure measurements Koo BK, Honda Y, Fitzgerald PJ. McGraw-Hill Specialty Board Review: Cardiology. 2011: 419-429
• Impact of donor-transmitted atherosclerosis on early cardiac allograft vasculopathy: new findings by three-dimensional intravascular ultrasound analysis. Yamasaki M, Sakurai R, Hirohata A, Honda Y, Bonneau HN, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Fearon WF. Transplantation. 2011; 91 (12): 1406-11
• Impact of polymer formulations on neointimal proliferation after zotarolimus-eluting stent with different polymers: insights from the RESOLUTE trial. Waseda K, Ako J, Yamasaki M, Koizumi T, Sakurai R, Hongo Y, Koo BK, Ormiston J, Worthley SG, Whitbourn RJ, Walters DL, Meredith IT, Fitzgerald PJ, Honda Y. Circ Cardiovasc Interv. 2011; 4 (3): 248-55
• Intravascular ultrasound Honda Y, Fitzgerald PJ, Yock PG. Textbook of Interventional Cardiology. 2011: 793-808
• Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions. Otake H, Honda Y, Courtney BK, Shimohama T, Ako J, Waseda K, Macours N, Rogers C, Popma JJ, Abizaid A, Ormiston JA, Spaulding C, Cohen SA, Fitzgerald PJ. Circ Cardiovasc Interv. 2011; 4 (2): 146-54
• Optical coherence tomography for patient-specific 3D artery reconstruction and evaluation of wall shear stress in a left circumflex coronary artery Laura M. Ellwein, Hiromasa Otake, Timothy J. Gundert, Bon-Kwon Koo, Toshiro Shinke, Yasuhiro Honda, Junya Shite, John F. LaDisa. Cardiovascular Engineering and Technology. 2011; 2 (3): 212-227
• Sex differences in neointimal hyperplasia following endeavor zotarolimus-eluting stent implantation. Nakatani D, Ako J, Tremmel JA, Waseda K, Otake H, Koo BK, Miyazawa A, Hongo Y, Hur SH, Sakurai R, Yock PG, Honda Y, Fitzgerald PJ. Am J Cardiol. 2011; 108 (7): 912-7
• Stent-assisted below-the-ankle angioplasty for limb salvage. Kawarada O, Yokoi Y, Higashimori A, Waratani N, Waseda K, Honda Y, Fitzgerald PJ. J Endovasc Ther. 2011; 18 (1): 32-42
• Mechanism of lumen gain with a novel rotational aspiration atherectomy system for peripheral arterial disease: examination by intravascular ultrasound. Hassan AH, Ako J, Waseda K, Honda Y, Zeller T, Leon MB, Fitzgerald PJ. Cardiovasc Revasc Med. 2010 Jul-Sep; 11 (3): 155-8
• Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trial. Koizumi T, Fitzgerald PJ, Honda Y, Ellis SG, Kent K, Martin SL, Brown CL, Masud AR, Patterson JB, Greenberg J, Friedman M, Uchida T, Stone GW. Cardiovasc Revasc Med. 2010 Jul-Sep; 11 (3): 140-8
• Anatomic and functional evaluation of bifurcation lesions undergoing percutaneous coronary intervention. Koo BK, Waseda K, Kang HJ, Kim HS, Nam CW, Hur SH, Kim JS, Choi D, Jang Y, Hahn JY, Gwon HC, Yoon MH, Tahk SJ, Chung WY, Cho YS, Choi DJ, Hasegawa T, Kataoka T, Oh SJ, Honda Y, Fitzgerald PJ, Fearon WF. Circ Cardiovasc Interv. 2010; 3 (2): 113-9
• Awareness of anatomical variations for infrapopliteral intervention. Kawarada O, Yokoi Y, Honda Y, Fitzgerald PJ. Catheter Cardiovasc Interv. 2010; 76 (6): 888-94
• Comparison of everolimus- versus paclitaxel-eluting stents implanted in patients with diabetes mellitus as evaluated by three-dimensional intravascular ultrasound analysis. Otake H, Ako J, Yamasaki M, Tsujino I, Shimohama T, Hasegawa T, Sakurai R, Waseda K, Honda Y, Sood P, Sudhir K, Stone GW, Fitzgerald PJ. Am J Cardiol. 2010; 106 (4): 492-7
• Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation: pooled IVUS results from the ZoMaxx I and II trials. Waseda K, Hasegawa T, Ako J, Honda Y, Grube E, Whitbourn R, Ormiston J, O'Shaughnessy CD, Henry TD, Overlie P, Schwartz LB, Sudhir K, Chevalier B, Gray WA, Yeung AC, Fitzgerald PJ. Circ J. 2010; 74 (11): 2334-9
• Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART). Kimura T, Morimoto T, Kozuma K, Honda Y, Kume T, Aizawa T, Mitsudo K, Miyazaki S, Yamaguchi T, Hiyoshi E, Nishimura E, Isshiki T. Circulation. 2010; 122 (1): 52-61
• Incidence of diffuse and focal chronic stent recoil after implantation of current generation bare-metal and drug-eluting stents. Koo BK, Waseda K, Ako J, Hasegawa T, Shimohama T, Nakatani D, Otake H, Yamasaki M, Sakurai R, Tsujino I, Honda Y, Fitzgerald PJ. Int J Cardiol. 2010; 144 (1): 132-4
• Neointimal hyperplasia in a thin-strut cobalt-chromium stent: insights from detailed 3-D intravascular ultrasound analysis. Otake H, Ako J, Waseda K, Sakurai R, Hirohata A, Kaneda H, Hasegawa T, Honda Y, Fitzgerald PJ. Int J Cardiol. 2010; 145 (1): 125-6
• Plaque Characterization - IVUS, OCT Sakata K, Honda Y, Yamagishi M. Current Therapy. 2010; 28 (5): 26-32
• SPIRIT III JAPAN versus SPIRIT III USA: a comparative intravascular ultrasound analysis of the everolimus-eluting stent. Shimohama T, Ako J, Yamasaki M, Otake H, Tsujino I, Hasegawa T, Nakatani D, Sakurai R, Chang H, Kusano H, Waseda K, Honda Y, Stone GW, Saito S, Fitzgerald PJ, Sudhir K. Am J Cardiol. 2010; 106 (1): 13-7
• Short- and mid-term intravascular ultrasound analysis of the new zotarolimus-eluting stent with durable polymer – results from the RESOLUTE trial –. Waseda K, Ako J, Yamasaki M, Koizumi T, Ormiston J, Worthley SG, Whitbourn RJ, Walters DL, Honda Y, Meredith IT, Fitzgerald PJ. Circ J. 2010; 74 (10): 2097-102
• Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial. Kaneda H, Ako J, Terashima M, Morino Y, Honda Y, Yock PG, Leon MB, Moses JW, Fitzgerald PJ. Int J Cardiol. 2010; 138 (2): 126-30
• Vascular response to overlapping everolimus-eluting stents. - Comparison with paclitaxel-eluting stents -. Otake H, Honda Y, Yamasaki M, Tsujino I, Shimohama T, Sakurai R, Hasegawa T, Waseda K, Ako J, Fitzgerald PJ. Circ J. 2010; 74 (5): 1023-5
• Late-acquired incomplete stent apposition: morphologic characterization. Hur SH, Ako J, Honda Y, Sudhir K, Fitzgerald PJ. Cardiovasc Revasc Med. 2009 Oct-Dec; 10 (4): 236-46
• A Novel Technique for Endovascular Detection and Removal of Radiographic Contrast during Angiography. Chang H, Hassan AH, Kim YL, Lloyd LJ, Koo BK, Ako J, Honda Y, Davidson CJ, Fitzgerald PJ. J Invasive Cardiol. 2009; 21 (7): 314-8
• A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study). Takagi T, Okura H, Kobayashi Y, Kataoka T, Taguchi H, Toda I, Tamita K, Yamamuro A, Sakanoue Y, Ito A, Yanagi S, Shimeno K, Waseda K, Yamasaki M, Fitzgerald PJ, Ikeno F, Honda Y, Yoshiyama M, Yoshikawa J. JACC Cardiovasc Interv. 2009; 2 (6): 524-31
• Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial. Hasegawa T, Ako J, Koo BK, Miyazawa A, Sakurai R, Chang H, Dens J, Verheye S, Grube E, Honda Y, Fitzgerald PJ. Catheter Cardiovasc Interv. 2009; 73 (1): 34-41
• Cardiovascular imaging: intravascular ultrasound Ako J, Yamasaki M, Honda Y, Fitzgerald, PJ. Interventional Cardiology: Current Best Practice. 2009: 206-211
• Drug-eluting stents. Insights from invasive imaging technologies. Honda Y, Circ J. 2009; 73 (8): 1371-80
• Drug-euting stents: current developments and future directions Nakatani D, Honda Y. Journal of Clinical an Experimental Medicine. 2009; 231 (6): 727-731
• Future directions of intravascular ultrasound Sakata K, Honda Y. The Lipid. 2009; 20 (1): 90-99
• IB-IVUS, Virtual Histology Sakata K, Honda Y. Journal of Clinical Echocardiography. 2009; 10 (8): 792-802
• Intraoperative fluorescence imaging system for on-site assessment of off-pump coronary artery bypass graft. Waseda K, Ako J, Hasegawa T, Shimada Y, Ikeno F, Ishikawa T, Demura Y, Hatada K, Yock PG, Honda Y, Fitzgerald PJ, Takahashi M. JACC Cardiovasc Imaging. 2009; 2 (5): 604-12
• Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, Yock PG, Honda Y, Kandzari DE, Leon MB, Fitzgerald PJ. JACC Cardiovasc Interv. 2009; 2 (8): 779-84
• Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography. Otake H, Shite J, Ako J, Shinke T, Tanino Y, Ogasawara D, Sawada T, Miyoshi N, Kato H, Koo BK, Honda Y, Fitzgerald PJ, Hirata K. JACC Cardiovasc Interv. 2009; 2 (5): 459-66
• Preprocedural inflammation does not affect neointimal hyperplasia following everolimus-eluting stent implantation. Nakatani D, Ako J, Yamasaki M, Shimohama T, Hasegawa T, Otake H, Waseda K, Tsujino I, Sakurai R, Koo BK, Chang H, Yock PG, Sudhir K, Pierson W, Stone GW, Saito S, Honda Y, Fitzgerald PJ. J Invasive Cardiol. 2009; 21 (12): 613-7
• Primary PCI for STEMI: hypothermia and myocardial regeneration therapy Kume T, Honda Y. Evidence Based Medicine: Treatment of Cardiovascular Disease 2010-2011. 2009: 39-43
• Scieitific support for clinical trials: the role and system of core laboratories in clinical research Waseda K, Honda Y. Coronary Intervention. 2009; 5 (6): 25-28
• Stent designs for bifurcation lesions: dedicated bifurcation stents Sakata K, Honda Y. Coronary Intervention. 2009; 5 (3): 33-40
• Stent expansion as a mechanical parameter to predict late stent patency: back to the basics. Honda Y, Fitzgerald PJ. JACC Cardiovasc Interv. 2009; 2 (12): 1276-8
• Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III. Miyazawa A, Ako J, Hongo Y, Hur SH, Tsujino I, Courtney BK, Hassan AH, Kandzari DE, Honda Y, Fitzgerald PJ. Am Heart J. 2008; 155 (1): 108-13
• Coronary risk factors and coronary atheroma burden at severely narrowing segments. Kaneda H, Kataoka T, Ako J, Honda Y, Yock PG, Fitzgerald PJ. Int J Cardiol. 2008; 124 (1): 124-6
• Effect of lumen narrowing within sirolimus-eluting stents on proximal and distal vessel segments. Waseda K, Ako J, Kaneda H, Miyazawa A, Shimada Y, Morino Y, Honda Y, Fitzgerald PJ. Circ J. 2008; 72 (4): 534-7
• Frontiers in intravascular imaging technologies. Honda Y, Fitzgerald PJ. Circulation. 2008; 117 (15): 2024-37
• Impact of additional ballooning on plaque prolapse after stent implantation in patients with acute myocardial infarction. Kaneda H, Honda Y, Fitzgerald PJ. JACC Cardiovasc Imaging. 2008; 1 (6): 815; author reply 815
• Intravascular ultrasound analysis of small-vessel lesions treated with novel ultra-low profile, guidewire-based self-expanding stent system. Koo BK, Yamasaki M, Ako J, Waseda K, Honda Y, Fitzgerald PJ, Abizaid A, Whitbourn RJ. J Invasive Cardiol. 2008; 20 (12): 647-50
• Novel guidewire-based stent delivery system: Examination by intravascular ultrasound. Yamasaki M, Ako J, Honda Y, Hassan A, Koo B, Abizaid A, Fitzgerald P, Whitbourn R. Catheter Cardiovasc Interv. 2008; 72 (1): 47-51
• Serial angiographic and intravascular ultrasound analysis of late stent strut fracture of sirolimus-eluting stents in native coronary arteries. Yamada KP, Koizumi T, Yamaguchi H, Kaneda H, Bonneau HN, Honda Y, Fitzgerald PJ. Int J Cardiol. 2008; 130 (2): 255-9
• Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study. Hur SH, Ako J, Shimada Y, Tsujino I, Hassan AH, Abizaid A, Shiran A, Lewis BS, Guagliumi G, Cohen SA, Honda Y, Fitzgerald PJ, Sousa JE. J Invasive Cardiol. 2008; 20 (8): 411-6
• Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial. Miyazawa A, Ako J, Hassan A, Hasegawa T, Abizaid A, Verheye S, McClean D, Neumann FJ, Grube E, Honda Y, Fitzgerald PJ. Catheter Cardiovasc Interv. 2007; 70 (7): 952-7
• Changes in coronary anatomy and physiology after heart transplantation. Hirohata A, Nakamura M, Waseda K, Honda Y, Lee DP, Vagelos RH, Hunt SA, Valantine HA, Yock PG, Fitzgerald PJ, Yeung AC, Fearon WF. Am J Cardiol. 2007; 99 (11): 1603-7
• Characterization of late incomplete stent apposition: a comparison among bare-metal stents, intracoronary radiation and sirolimus-eluting stents. Miyazawa A, Tsujino I, Ako J, Shimada Y, Courtney BK, Sakurai R, Nakamura M, Okura H, Waseda K, Honda Y, Fitzgerald PJ. J Invasive Cardiol. 2007; 19 (12): 515-8
• Comparison of nonuniform strut distribution between two drug-eluting stent platforms. Hasegawa T, Ako J, Ikeno F, Waseda K, Suzuki Y, Honda Y, Fitzgerald PJ. J Invasive Cardiol. 2007; 19 (6): 244-6
• Comparison of vessel response following sirolimus-eluting stent implantation as assessed by serial 3-D intravascular ultrasound study. Waseda K, Ako J, Shimada Y, Morino Y, Tsujino I, Hongo Y, Sudhir K, Yock PG, Fitzgerald PJ, Honda Y. J Invasive Cardiol. 2007; 19 (4): 171-3
• Design criteria for the ideal drug-eluting stent. Ako J, Bonneau HN, Honda Y, Fitzgerald PJ. Am J Cardiol. 2007; 100 (8B): 3M-9M
• Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Sakurai R, Hongo Y, Yamasaki M, Honda Y, Bonneau HN, Yock PG, Cutlip D, Popma JJ, Zimetbaum P, Fajadet J, Kuntz RE, Wijns W, Fitzgerald PJ. Am J Cardiol. 2007; 100 (5): 818-23
• Determinants of lumen loss between years 1 and 2 after cardiac transplantation. Sakurai R, Yamasaki M, Nakamura M, Hirohata A, Honda Y, Bonneau HN, Luikart H, Yock PG, Fitzgerald PJ, Yeung AC, Valantine HA, Fearon WF. Transplantation. 2007; 84 (9): 1097-102
• Drug delivery via nano-, micro and macroporous coronary stent surfaces. Tsujino I, Ako J, Honda Y, Fitzgerald PJ. Expert Opin Drug Deliv. 2007; 4 (3): 287-95
• Efficacy of reduced-dose sirolimus-eluting stents in the human coronary artery: serial IVUS analysis of neointimal hyperplasia and luminal dimension. Nakamura M, Abizaid A, Hirohata A, Honda Y, Sousa JE, Fitzgerald PJ. Catheter Cardiovasc Interv. 2007; 70 (7): 946-51
• Future directions of drug-eluting stents in the treatment of acute coronary syndrome Waseda K, Honda Y. Coronary Intervention. 2007; 3 (1): 94-99
• Impact of gender on neointimal hyperplasia following coronary artery stenting. Kaneda H, Ako J, Kataoka T, Takahashi T, Terashima M, Waseda K, Miyazawa A, Hassan AH, Honda Y, Yock PG, Fitzgerald PJ. Am J Cardiol. 2007; 99 (4): 491-3
• Intravascular ultrasound Honda Y, Fitzgerald PJ, Yock PG. Textbook of Interventional Cardiology. 2007: 1115-1142
• Intravascular ultrasound Hur SH, Honda Y, Fitzgerald PJ, Yock PG. Cardiovasuclar Medicine. 2007: 1797-1810
• Intravascular ultrasound findings in ENDEAVOR II and ENDEAVOR III. Sakurai R, Bonneau HN, Honda Y, Fitzgerald PJ. Am J Cardiol. 2007; 100 (8B): 71M-76M
• Neointimal progression and luminal narrowing in sirolimus-eluting stent treatment for bare metal in-stent restenosis: a quantitative intravascular ultrasound analysis. Sakurai R, Ako J, Hassan AH, Bonneau HN, Neumann FJ, Desmet W, Holmes DR, Yock PG, Fitzgerald PJ, Honda Y. Am Heart J. 2007; 154 (2): 361-5
• Serial intravascular ultrasonic study of outcomes of coronary culprit lesions with plaque rupture following bare metal stent implantation in patients with angina pectoris. Hur SH, Hassan AH, Rekhi R, Ako J, Shimada Y, Nakamura M, Yamasaki M, Bonneau HN, Sudhir K, Yock PG, Honda Y, Fitzgerald PJ. Am J Cardiol. 2007; 99 (10): 1394-8
• The risks and benefits of drug-eluting stents. Shimohama T, Honda Y, Fitzgerald PJ. Am Heart Hosp J. 2007; 5 (3): 146-50
• Available transcatheter mitral valve repair techniques: CS method Ako J, Hassan A, Honda Y, Fitzgerald PJ. Transcathter Valve Repair. 2006: 285-294
• Axial plaque redistribution after coronary stent deployment. Hirohata A, Honda Y, Fitzgerald P. J Invasive Cardiol. 2006; 18 (8): E225-6
• Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial). Hirohata A, Morino Y, Ako J, Sakurai R, Buchbinder M, Caputo RP, Karas SP, Mishkel GJ, Mooney MR, O'shaughnessy CD, Raizner AE, Wilensky RL, Williams DO, Wong SC, Yock PG, Honda Y, Moses JW, Fitzgerald PJ. Am J Cardiol. 2006; 98 (11): 1464-7
• Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus. Kaneda H, Ako J, Kataoka T, Takahashi T, Terashima M, Waseda K, Miyazawa A, Hassan A, Honda Y, Yock PG, Fitzgerald PJ. Am J Cardiol. 2006; 97 (3): 340-2
• Influence of plaque calcium on neointimal hyperplasia following bare metal and drug-eluting stent implantation. Shimada Y, Kataoka T, Courtney BK, Morino Y, Bonneau HN, Yock PG, Grube E, Honda Y, Fitzgerald PJ. Catheter Cardiovasc Interv. 2006; 67 (6): 866-9
• Intravascular imaging techniques Honda Y, Fitzgerald PJ, Yock PG. Cardiac Catheterization, Angioplasty and Intervention. 2006: 371-394
• Intravascular ultrasonic analysis of atherosclerotic vessel remodeling and plaque distribution of stenotic left anterior descending coronary arterial bifurcation lesions upstream and downstream of the side branch. Shimada Y, Courtney BK, Nakamura M, Hongo Y, Sonoda S, Hassan AH, Yock PG, Honda Y, Fitzgerald PJ. Am J Cardiol. 2006; 98 (2): 193-6
• Mechanisms of lumen narrowing of saphenous vein bypass grafts 12 months after implantation: an intravascular ultrasound study. Kaneda H, Terashima M, Takahashi T, Iversen S, Felderhoff T, Grube E, Yock PG, Honda Y, Fitzgerald PJ. Am Heart J. 2006; 151 (3): 726-9
• Next generation drug-eluting stents Honda Y, Drug-Eluting Stent 2. 2006: 100-105
• Predictors of recurrent in-stent restenosis after beta-radiation: An analysis from the START 40/20 trial. Kaneda H, Honda Y, Morino Y, Lansky AJ, Yock PG, Bonan R, Fitzgerald PJ. J Interv Cardiol. 2006; 19 (5): 376-80
• Safety of beta radiation exposure to the non-target segment: an intravascular ultrasound dosimetric analysis. Kaneda H, Honda Y, Morino Y, Fox T, Crocker I, Lansky AJ, Yock PG, Bonan R, Fitzgerald PJ. J Invasive Cardiol. 2006; 18 (7): 309-12
• Transient left ventricular dysfunction under severe stress: brain-heart relationship revisited. Ako J, Sudhir K, Farouque HM, Honda Y, Fitzgerald PJ. Am J Med. 2006; 119 (1): 10-7
• Effect of lumen narrowing within coronary stents on proximal and distal vessel segments following bare metal stent implantation. Kaneda H, Ako J, Kataoka T, Miyazawa A, Terashima M, Ikeno F, Sonoda S, Shimada Y, Morino Y, Honda Y, Yock PG, Fitzgerald PJ. Am J Cardiol. 2005; 96 (3): 376-8
• Future directions of drug-eluting stent technology Honda Y, Coronary Intervention. 2005; 1 (1): 96-101
• Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation. Kaneda H, Ako J, Honda Y, Terashima M, Morino Y, Yock PG, Popma JJ, Leon MB, Moses JW, Fitzgerald PJ. Am J Cardiol. 2005; 96 (10): 1404-7
• Impact of different definitions on the interpretation of coronary remodeling determined by intravascular ultrasound. Hibi K, Ward MR, Honda Y, Suzuki T, Jeremias A, Okura H, Hassan AH, Maehara A, Yeung AC, Pasterkamp G, Fitzgerald PJ, Yock PG. Catheter Cardiovasc Interv. 2005; 65 (2): 233-9
• Impact of intravascular ultrasound lesion characteristics on neointimal hyperplasia following sirolimus-eluting stent implantation. Kaneda H, Koizumi T, Ako J, Terashima M, Morino Y, Honda Y, Yock PG, Leon MB, Moses JW, Fitzgerald PJ. Am J Cardiol. 2005; 96 (9): 1237-41
• Impending coronary perforation after cutting balloon angioplasty. Ako J, Honda Y, Fitzgerald PJ. Heart. 2005; 91 (1): e8
• Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, Leon MB, Moses JW, Bonneau HN, Fitzgerald PJ. J Am Coll Cardiol. 2005; 46 (6): 1002-5
• New treatment technologies for coronary artery disease: other techniques Hongo Y, Honda Y. Practical Cardiology: Coronary Artery Disease II. 2005: 5 158-164
• Percutaneous coronary sinus repair of mitral regurgitation Ikeno F, Honda Y, Bonneau HN, Hassan AHM, Fitzgerald PJ. Interventional Cardiology: Current Best Practice. 2005: 69-86
• Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Sakurai R, Ako J, Morino Y, Sonoda S, Kaneda H, Terashima M, Hassan AH, Leon MB, Moses JW, Popma JJ, Bonneau HN, Yock PG, Fitzgerald PJ, Honda Y. Am J Cardiol. 2005; 96 (9): 1251-3
• Transient left ventricular apical ballooning. Ako J, Honda Y, Fitzgerald PJ. Ann Intern Med. 2005; 142 (8): 678; author reply 678-9
• ABT-578-eluting stent Hongo Y, Honda Y, Fitzgerald PJ. Drug-Eluting Stent. 2004: 98-100
• Conditions associated with ST-segment elevation. Ako J, Honda Y, Fitzgerald PJ. N Engl J Med. 2004; 350 (11): 1152-5; author reply 1152-5
• Dexamethasone-eluting stent (Dexamet™) Sakurai R, Honda Y, Fitzgerald PJ. Drug-Eluting Stent. 2004: 83-88
• Drug-eluting stent for the treatment of in-stent restenosis Kataoka T, Honda Y, Fitzgerald PJ. Drug-Eluting Stent. 2004: 116-122
• Drug-eluting stent: basic components Ako J, Honda Y, Fitzgerald PJ. Drug-Eluting Stent. 2004: 40-50
• Estradiol-eluting stent Sakurai R, Honda Y, Fitzgerald PJ. Drug-Eluting Stent. 2004: 101-104
• IVUS observations of drug-eluting stents Honda Y, Fitzgerald PJ. Drug-Eluting Stent. 2004: 128-138
• Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. Sonoda S, Morino Y, Ako J, Terashima M, Hassan AH, Bonneau HN, Leon MB, Moses JW, Yock PG, Honda Y, Kuntz RE, Fitzgerald PJ. J Am Coll Cardiol. 2004; 43 (11): 1959-63
• Left main coronary disease: an IVUS perspective Shimada Y, Honda Y. Coronary Intervention. 2004; 3 (2): 16-22
• Lessons from failed drug-eluting stents Sonoda S, Honda Y, Fitzgerald PJ. Drug-Eluting Stent. 2004: 111-115
• Other drug-eluting stents Kaneda H, Honda Y, Fitzgerald PJ. Drug-Eluting Stent. 2004: 105-110
• Paclitaxel-eluting stent Morino Y, Nakamura M, Kataoka T, Honda Y, Fitzgerald PJ. Jpn J Cardiovasc Ther. 2004; 4 (2): 148-153
• Paclitaxel-eluting stent Nakamura M, Honda Y, Fitzgerald PJ. Drug-Eluting Stent. 2004: 74-82
• Sirolimus-eluting stent (CYPHER™) Morino Y, Honda Y, Fitzgerald PJ. Drug-Eluting Stent. 2004: 63-73
• Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer. Grube E, Sonoda S, Ikeno F, Honda Y, Kar S, Chan C, Gerckens U, Lansky AJ, Fitzgerald PJ. Circulation. 2004; 109 (18): 2168-71
• Thrombectomy and distal protection: protection of coronary microcirculation and myocardium Honda Y, Coronary Intervention. 2004: 199-206
• Validation of a thermographic guidewire for endoluminal mapping of atherosclerotic disease: an in vitro study. Courtney BK, Nakamura M, Tsugita R, Lilly R, Basisht R, Grube E, Honda Y, Yock PG, Fitzgerald PJ. Catheter Cardiovasc Interv. 2004; 62 (2): 221-9
• Coronary vasodilation by noninvasive transcutaneous ultrasound: an in vivo canine study. Miyamoto T, Neuman Y, Luo H, Jeon DS, Kobal S, Ikeno F, Horzewski M, Honda Y, Mirocha JM, Iwami T, Echt D, Fishbein MC, Siegel RJ. J Am Coll Cardiol. 2003; 41 (9): 1623-7
• IVUS guided stenting - optimizing outcomes Sakurai R, Honda Y, Bonneau HN, Fitzgerald PJ. Coronary Intervention. 2003; 2 (2): 26-30
• Impact of deep vessel wall injury on acute response and remodeling of coronary artery segments after cutting balloon angioplasty. Nakamura M, Yock PG, Kataoka T, Bonneau HN, Suzuki T, Yamaguchi T, Honda Y, Fitzgerald PJ. Am J Cardiol. 2003; 91 (1): 6-11
• Late incomplete apposition with excessive remodeling of the stented coronary artery following intravascular brachytherapy. Okura H, Lee DP, Lo S, Yeung AC, Honda Y, Waksman R, Kaluza GL, Ali NM, Bonneau HN, Yock PG, Raizner AE, Mintz GS, Fitzgerald PJ. Am J Cardiol. 2003; 92 (5): 587-90
• Late incomplete stent apposition and focal vessel expansion after bare metal stenting. Nakamura M, Kataoka T, Honda Y, Bonneau HN, Hibi K, Kitamura K, Tamai H, Aizawa T, Yock PG, Fitzgerald PJ. Am J Cardiol. 2003; 92 (10): 1217-9
• New technologies for the treatment of acute myocardial infarction: ongoing clinical trials in the United States and Europe Honda Y, Cardioangiology. 2003: 54 70-79
• Noninvasive transcutaneous ultrasound augments thrombolysis in the left circumflex coronary artery--an in vivo canine study. Jeon DS, Luo H, Fishbein MC, Miyamoto T, Horzewski M, Iwami T, Mirocha JM, Ikeno F, Honda Y, Siegel RJ. Thromb Res. 2003; 110 (2-3): 149-58
• Percutaneous intervention by the coronary venous route Honda Y, Hayase M. Heart View. 2003; 7 (2): 58-64
• Relationship between neointimal regrowth and mechanism of acute lumen gain during the treatment of in-stent restenosis with or without supplementary intravascular radiation. Morino Y, Limpijankit T, Honda Y, Somrantin M, Waksman R, Bonneau HN, Yock PG, Mintz GS, Fitzgerald PJ. Catheter Cardiovasc Interv. 2003; 58 (2): 162-7
• Stent thrombosis: an issue revisited in a changing world. Honda Y, Fitzgerald PJ. Circulation. 2003; 108 (1): 2-5
• Tako-tsubo-like left ventricular dysfunction. Ako J, Honda Y, Fitzgerald PJ. Circulation. 2003; 108 (23): e158; author reply e158
• Taxol-based eluting stents from theory to human validation: clinical and intravascular ultrasound observations. Sonoda S, Honda Y, Kataoka T, Bonneau HN, Sudhir K, Yock PG, Mintz GS, Fitzgerald PJ. J Invasive Cardiol. 2003; 15 (3): 109-14
• What do cardiologists want from vascular ultrasound? Kaneda H, Honda Y, Fitzgerald PJ. Vascular Ultrasound. 2003: 3-27
• Impact of insulin resistance on neointimal tissue proliferation after coronary stent implantation. Intravascular ultrasound studies. Takagi T, Akasaka T, Yamamuro A, Honda Y, Hozumi T, Morioka S, Yoshida K. J Diabetes Complications. 2002 Jan-Feb; 16 (1): 50-5
• 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE). Kataoka T, Grube E, Honda Y, Morino Y, Hur SH, Bonneau HN, Colombo A, Di Mario C, Guagliumi G, Hauptmann KE, Pitney MR, Lansky AJ, Stertzer SH, Yock PG, Fitzgerald PJ. Circulation. 2002; 106 (14): 1788-93
• Combining a drug-eluting stent and platelet glycoprotein IIb/IIIa inhibition in a patient with acute coronary syndrome Kaneda H, Honda Y, Fitzgerald PJ. J Invasive Cardiol. 2002; 4 (16)
• Coronary intravascular ultrasonography Staehr P, Honda Y, Fitzgerald PJ, Yock PG. PanVascular Medicine: Integrated Clinical Management. 2002: 667-678
• Delivered dose and vascular response after beta-radiation for in-stent restenosis: retrospective dosimetry and volumetric intravascular ultrasound analysis. Morino Y, Kaneda H, Fox T, Takagi A, Hassan AH, Bonan R, Crocker I, Lansky AJ, Laskey WK, Suntharalingam M, Bonneau HN, Yock PG, Honda Y, Fitzgerald PJ. Circulation. 2002; 106 (18): 2334-9
• Efficacy and feasibility of helixcision for debulking neointimal hyperplasia for in-stent restenosis. Nakamura M, Fitzgerald PJ, Ikeno F, Honda Y, Sousa JE, Abizaid A, de Brito FS, Tofte A, Grube E, Patterson GR, Yock PG, Yeung AC, Carter AJ. Catheter Cardiovasc Interv. 2002; 57 (4): 460-6
• Images in cardiovascular medicine. "Arteries within the artery" after Kawasaki disease: a lotus root appearance by intravascular ultrasound. Terashima M, Awano K, Honda Y, Yoshino N, Mori T, Fujita H, Ohashi Y, Seguchi O, Kobayashi K, Yamagishi M, Fitzgerald PJ, Yock PG, Maeda K. Circulation. 2002; 106 (7): 887
• Intravascular ultrasound Honda Y, Fitzgerald PJ, Yock PG. Textbook of Interventional Cardiology. 2002: 893-917
• Intravascular ultrasound and quantitative coronary angiography. Takahashi T, Honda Y, Russo RJ, Fitzgerald PJ. Catheter Cardiovasc Interv. 2002; 55 (1): 118-28
• Intravascular ultrasound observations for stented and non-stented procedures Hur SH, Honda Y, Bonneau HN, Yock PG, Fitzgerald PJ. Vascular Brachytherapy. 2002: 581-603
• Late vascular response to repeat stenting for in-stent restenosis with and without radiation: an intravascular ultrasound volumetric analysis. Morino Y, Limpijankit T, Honda Y, Lansky AJ, Waksman R, Bonneau HN, Yock PG, Mintz GS, Fitzgerald PJ. Circulation. 2002; 105 (21): 2465-8
• New catheter-based technology for the treatment of restenosis. Kataoka T, Honda Y, Bonneau HN, Yock PG, Fitzgerald PJ. J Interv Cardiol. 2002; 15 (5): 371-9
• New technology for the treatment of acute myocardial infarction: how to protect coronary microcirculation and myocardium Honda Y, Coronary Intervention. 2002; 1 (4): 99-105
• New technology for the treatment of acute myocardial infarction: how to protect coronary microcirculation and myocardium Honda Y, Coronary Intervention. 2002; 1 (4): 99-105
• Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, Fitzgerald PJ, Yock PG. Eur Heart J. 2002; 23 (2): 124-32
• Prevention of restenosis: sonotheraphy, photoangioplasty and cryotherapy Morino Y, Kataoka T, Honda Y, Fitzgerald PJ. Cardiology New Trends: New Trends in Coronary Intervention. 2002: 138-147
• Quantitative and spatial relation of baseline atherosclerotic plaque burden and subsequent in-stent neointimal proliferation as determined by intravascular ultrasound. Hibi K, Suzuki T, Honda Y, Hayase M, Bonneau HN, Yock PG, Yeung AC, Fitzgerald PJ. Am J Cardiol. 2002; 90 (10): 1164-7
• An optimal diagnostic threshold for minimal stent area to predict target lesion revascularization following stent implantation in native coronary lesions. Morino Y, Honda Y, Okura H, Oshima A, Hayase M, Bonneau HN, Kuntz RE, Yock PG, Fitzgerald PJ. Am J Cardiol. 2001; 88 (3): 301-3
• Efficacy of postdeployment balloon dilatation for current generation stents as assessed by intravascular ultrasound. Hur SH, Kitamura K, Morino Y, Honda Y, Jones M, Korr KS, Reen B, Cooper CJ, Niess GS, Christie L, Corey W, Messenger J, Yock PG, Cummins F, Fitzgerald PJ. Am J Cardiol. 2001; 88 (10): 1114-9
• Future direction of intravascular ultrasound Honda Y, Kobayashi Y. Clinical Echocardiography. 2001: 267-275
• Impact of peri-stent remodeling on restenosis: a volumetric intravascular ultrasound study. Nakamura M, Yock PG, Bonneau HN, Kitamura K, Aizawa T, Tamai H, Fitzgerald PJ, Honda Y. Circulation. 2001; 103 (17): 2130-2
• Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE Trial.A Stent vs. Stent Ultrasound Remodeling Evaluation. Kobayashi Y, Honda Y, Christie GL, Teirstein PS, Bailey SR, Brown CL, Matthews RV, De Franco AC, Schwartz RS, Goldberg S, Popma JJ, Yock PG, Fitzgerald PJ. J Am Coll Cardiol. 2001; 37 (5): 1329-34
• Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system. Honda Y, Grube E, de La Fuente LM, Yock PG, Stertzer SH, Fitzgerald PJ. Circulation. 2001; 104 (4): 380-3
• Principles of intravascular ultrasound Honda Y, Kobayashi Y. Clinical Echocardiography. 2001: 252-259
• Stanford University Honda Y, Journal of Clinical Echocardiography. 2001
• The effect of intracoronary gamma-radiation therapy for in-stent restenosis: an intravascular ultrasound study. Limpijankit T, Honda Y, Mehran R, Waksman R, Lansky AJ, Mintz GS, Yock PG, Fitzgerald PJ. Cardiovasc Radiat Med. 2001; 2 (1): 54
• The renaissance of directional coronary atherectomy: a second look from the inside. Honda Y, Fitzgerald PJ. J Invasive Cardiol. 2001; 13 (11): 748-51
• The role of IVUS in the prevention and treatment of restenosis Shimodozono S, Honda Y, Bonneau HN, Fitzgerald PJ. Restenosis: A Guide to Therapy. 2001: 77-95
• The role of intravascular ultrasound in clinical trials Honda Y, Clinical Echocardiography. 2001: 265-267
• Vascular brachytherapy: from theory to practice Morino Y, Takagi A, Honda Y, Fitzgerald PJ. Coronary Angioplasty and Intravascular Ultrasound for Brachytherapy. 2001: 121-141
• Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickening. Ikonen TS, Gummert JF, Serkova N, Hayase M, Honda Y, Kobayase Y, Hausen B, Yock PG, Christians U, Morris RE. Transpl Int. 2000: 13 Suppl 1 S314-20
• Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study. Takagi T, Yoshida K, Akasaka T, Kaji S, Kawamoto T, Honda Y, Yamamuro A, Hozumi T, Morioka S. J Am Coll Cardiol. 2000; 36 (3): 731-8
• Intravascular ultrasound Honda Y, Kobayashi Y. Diagnosis of Coronary Artery Disease. 2000: 104-115
• Longitudinal plaque redistribution during stent expansion. Maehara A, Takagi A, Okura H, Hassan AH, Bonneau HN, Honda Y, Yock PG, Fitzgerald PJ. Am J Cardiol. 2000; 86 (10): 1069-72
• Multidimensional assessment of graft vascular disease (GVD) in aortic grafts by serial intravascular ultrasound in rhesus monkeys. Ikonen TS, Briffa N, Gummert JF, Honda Y, Hayase M, Hausen B, Billingham ME, Yock PG, Robbins RC, Morris RE. Transplantation. 2000; 70 (3): 420-9
• Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates. Ikonen TS, Gummert JF, Hayase M, Honda Y, Hausen B, Christians U, Berry GJ, Yock PG, Morris RE. Transplantation. 2000; 70 (6): 969-75
• Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study. Takagi T, Akasaka T, Yamamuro A, Honda Y, Hozumi T, Morioka S, Yoshida K. J Am Coll Cardiol. 2000; 36 (5): 1529-35
• Development of models of graft vascular disease in nonhuman primates: evaluation of GVD by intravascular ultrasound in a new cynomolgus model with arterial allograft exchange. Ikonen TS, Gummert JF, Honda Y, Hayase M, Perlroth J, Hausen B, Barlow C, Fitzgerald P, Yock PG, Morris RE. Transplant Proc. 1999 Feb-Mar; 31 (1-2): 687
• Feasibility of in vivo intravascular ultrasound tissue characterization in the detection of early vascular transplant rejection. Jeremias A, Kolz ML, Ikonen TS, Gummert JF, Oshima A, Hayase M, Honda Y, Komiyama N, Berry GJ, Morris RE, Yock PG, Fitzgerald PJ. Circulation. 1999; 100 (21): 2127-30
• Impact of residual plaque burden on clinical outcomes of coronary interventions. Honda Y, Yock PG, Fitzgerald PJ. Catheter Cardiovasc Interv. 1999; 46 (3): 265-76
• Intravascular ultrasound Yock PG, Fitzgerald PJ, Honda Y. Textbook of Interventional Cardiology. 1999: 801-818
• A new large-animal model for research of graft vascular disease. Gummert JF, Ikonen T, Briffa N, Honda Y, Hayase M, Perlroth J, Kobayashi Y, Hausen B, Barlow C, Billingham ME, Fitzgerald P, Yock PG, Robbins RC, Morris RE. Transplant Proc. 1998; 30 (8): 4023
• Stanford University Medical Center Honda Y, The Circulation Frontier. 1998; 2 (3): 81-84
• Quantitative Assessment of Cardiac Hemodynamics by Doppler Echocardiography Honda Y, Yoshikawa J, Nishimura RA, Watanabe H, Yamamuro A. Quantitative Assessment of Cardiac Hemodynamics by Doppler Echocardiography. 1998
• Impact of curve distortion errors on intravascular ultrasound measurements and three-dimensional reconstructions. Schwarzacher SP, Honda Y, Metz JA, Asvar CA, Fitzgerald PJ, Yock PG. Am J Cardiol. 1997; 79 (3): 384-7
• Phonocardiography Honda Y, Yoshikawa J. Evidence Based Medicine. 1997: 478-481
• The value of IVUS guidance in directional atherectomy Honda Y, Yock PG, Fitzgerald PJ. Current Review of Interventional Cardiology. 1997: 1-11
• Use of intravascular ultrasound for in vivo assessment of changes in intimal thickness of angiographically normal saphenous vein grafts one year after aortocoronary bypass surgery. Hozumi T, Yoshikawa J, Yoshida K, Akasaka T, Takagi T, Honda Y, Okura H. Heart. 1996; 76 (4): 317-20
• Value and limitations of 'aortic valve resistance' in assessing severity of aortic stenosis in patients with low pressure gradient : a clinical study using dobutamine stress echocardiography Okura H, Yoshida K, Akasaka T, Shakudo M, Hozumi T, Takagi T, Honda Y, Yamamuro A, Yoshikawa J. Jpn J Med Ultrasonics. 1996; 23 (4): 287
• [Evaluation of left ventricular volume and ejection fraction using three-dimensional transesophageal echocardiography]. Yagi T, Yoshida K, Hozumi T, Akasaka T, Takagi T, Honda Y, Ohkura H, Yamamuro A, Yoshikawa J. J Cardiol. 1996; 27 (4): 207-10
• [Phasic flow velocity characteristics of the right coronary artery in patients with aortic stenosis: a Doppler guide wire study]. Okura H, Yoshida K, Akasaka T, Shakudo M, Hozumi T, Takagi T, Honda Y, Yamamuro A, Watanabe H, Yoshikawa J. J Cardiol. 1996; 27 (5): 255-9
• [Prognostic value of serial Doppler echocardiographic follow-up of transmitral flow patterns in patients with congestive heart failure who presented with pulmonary edema]. Yamamuro A, Yoshida K, Akasaka T, Hozumi T, Takagi T, Honda Y, Okura H, Yoshikawa J. J Cardiol. 1996; 27 (6): 321-7
• [Value and limitations of valve resistance in assessing prosthetic aortic valve function: clinical study using dobutamine stress doppler echocardiography]. Okura H, Yoshikawa J, Yoshida K, Akasaka T, Shakudo M, Hozumi T, Takagi T, Honda Y, Yamamuro A. J Cardiol. 1996; 27 (1): 9-13
• [Assessment of coronary stenosis severity using a Doppler guide wire in vivo: is the continuity equation applicable to moderate to severe coronary artery stenosis?]. Hozumi T, Yoshikawa J, Yoshida K, Akasaka T, Shakudo M, Takagi T, Honda Y, Okura H. J Cardiol. 1995; 25 (1): 1-7
• [Detection of hibernating myocardium in patients with myocardial infarction by low-dose dobutamine echocardiography: comparison with thallium-201 scintigraphy with reinjection]. Takagi T, Yoshikawa J, Yoshida K, Akasaka T, Honda Y, Yonezawa Y, Shakudo M. J Cardiol. 1995; 25 (4): 155-61
• [Intravascular ultrasound scanning assessment of plaque distribution in the left anterior descending coronary artery just distal to the bifurcation]. Watanabe H, Yoshikawa J, Yoshida K, Akasaka T, Hozumi T, Takagi T, Honda Y, Okura H, Yamamuro A. J Cardiol. 1995; 26 (6): 325-9
• [Pseudoxanthoma elasticum associated with unstable angina and Leriche syndrome: a case report]. Hiragi T, Yoshikawa J, Okura H, Honda Y, Akasaka T. J Cardiol. 1995; 26 (1): 43-9
• [Relationship between regional flow reserve supplied by the great saphenous vein graft and regional left ventricular wall motion: a Doppler guide wire study]. Fukuda H, Yoshikawa J, Yoshida K, Akasaka T, Shakudo M, Takagi T, Hozumi T, Maeda K, Miyake S, Honda Y. J Cardiol. 1995; 25 (2): 83-8
• [Usefulness and limitations of dobutamine stress echocardiography for detection of coronary artery disease]. Takagi T, Yoshikawa J, Yoshida K, Akasaka T, Honda Y, Maenishi A. J Cardiol. 1994 Sep-Oct; 24 (5): 347-55
• Aortic dissection: early diagnosis and treatment Honda Y, Akasaka T, Yoshikawa J. Gendai-Iryo. 1994; 26 (1): 233-238
• Intravascular ultrasound imaging in renal bifurcation with a reference to the location and development of atherosclerosis Fukuda H, Yoshikawa J, Yoshida K, Akasaka T, Shakudo M, Hozumi T, Miyake S, Honda Y. Jpn J Med Ultrasonics. 1994: 21 451-454
• Syndrome X and coronary angiography Honda Y, Akasaka T. Practical Cardiology. 1994: 2 94-96
• The effect of a trackball-derived region of interest on left ventricular volume using an acoustic quantification method Yagi T, Yoshikawa J, Yoshida K, Akasaka T, Shakudo M, Hozumi T, Miyake S, Okura H, Honda Y. Jpn J Med Ultrasonics. 1994: 21 489-494
• [Clinical characteristics and surgical treatment of atrial septal defect in adults]. Akasaka T, Yoshikawa J, Yoshida K, Hozumi T, Honda Y, Okura H, Yamamuro A. Jpn Circ J. 1994: 58 Suppl 4 1250-4